Boyu Capital Fund IV, L.P - Net Worth and Insider Trading

Boyu Capital Fund IV, L.P Net Worth

The estimated net worth of Boyu Capital Fund IV, L.P is at least $535 Million dollars as of 2024-06-22. Boyu Capital Fund IV, L.P is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics and owns about 78,214,230 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $535 Million. Details can be seen in Boyu Capital Fund IV, L.P's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Boyu Capital Fund IV, L.P has not made any transactions after 2021-12-21 and currently still holds the listed stock(s).

Transaction Summary of Boyu Capital Fund IV, L.P

To

Boyu Capital Fund IV, L.P Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Boyu Capital Fund IV, L.P owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .

Click here to see the complete history of Boyu Capital Fund IV, L.P’s form 4 insider trades.

Insider Ownership Summary of Boyu Capital Fund IV, L.P

Ticker Comapny Transaction Date Type of Owner
HKSE:01477 Ocumension Therapeutics 2021-12-21 2201 Interest of corporation controlled by you

Boyu Capital Fund IV, L.P Latest Holdings Summary

Boyu Capital Fund IV, L.P currently owns a total of 1 stock. Boyu Capital Fund IV, L.P owns 78,214,230 shares of Ocumension Therapeutics (HKSE:01477) as of December 21, 2021, with a value of $535 Million.

Latest Holdings of Boyu Capital Fund IV, L.P

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01477 Ocumension Therapeutics 2021-12-21 78,214,230 6.84 534,985,333

Holding Weightings of Boyu Capital Fund IV, L.P


Boyu Capital Fund IV, L.P Form 4 Trading Tracker

According to the SEC Form 4 filings, Boyu Capital Fund IV, L.P has made a total of 1 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Ocumension Therapeutics is the sale of 0 shares on December 21, 2021, which brought Boyu Capital Fund IV, L.P around $0.

Insider Trading History of Boyu Capital Fund IV, L.P

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Boyu Capital Fund IV, L.P Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Boyu Capital Fund IV, L.P Ownership Network

Ownership Network List of Boyu Capital Fund IV, L.P

No Data

Ownership Network Relation of Boyu Capital Fund IV, L.P

Insider Network Chart

Boyu Capital Fund IV, L.P Owned Company Details

What does Ocumension Therapeutics do?

Who are the key executives at Ocumension Therapeutics?

Boyu Capital Fund IV, L.P is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2201 Interest of corporation controlled by you Temasek Holdings (private) Limited , 2101 Beneficial owner Liu Ye , and 2201 Interest of corporation controlled by you Boyu Capital Group Holdings Ltd .

Ocumension Therapeutics (HKSE:01477) Insider Trades Summary

Over the past 18 months, Boyu Capital Fund IV, L.P made no insider transaction in Ocumension Therapeutics (HKSE:01477). Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 500 shares made by Liu Ye , a net sale of 3,800,000 shares made by Temasek Holdings (private) Limited , and a net sale of 427,000 shares made by The Capital Group Companies, Inc. .

In summary, during the past 3 months, insiders sold 1,500,000 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,227,500 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,500 shares.

Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ocumension Therapeutics Insider Transactions

No Available Data

Boyu Capital Fund IV, L.P Mailing Address

Above is the net worth, insider trading, and ownership report for Boyu Capital Fund IV, L.P. Currently GuruFocus does not have mailing address information for Boyu Capital Fund IV, L.P.

Discussions on Boyu Capital Fund IV, L.P

No discussions yet.